---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-019663"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2025-07-15T23:59:59+00:00"
generated_at: "2026-05-18T06:29:05.387783+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Processa Pharmaceuticals adjourns annual meeting due to lack of quorum; reconvened on July 18, 2025

## Summary
- Annual meeting on June 30, 2025, adjourned due to insufficient quorum; no business conducted.
- Meeting reconvened on July 18, 2025, at 9:00 AM in Hanover, MD; record date unchanged (May 1, 2025).
- Proxies already submitted remain valid; no action needed for shareholders who have already voted.

## SEC filing metadata
- accession: 0001641172-25-019663
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2025-07-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000164117225019663/0001641172-25-019663-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000164117225019663/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-019663
- JSON: https://secwatch.observer/filing/0001641172-25-019663.json
- Plain text: https://secwatch.observer/filing/0001641172-25-019663.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.